BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TCL1A, P56279, 8115, ENSG00000100721, TCL1 AND Diagnosis
20 results:

  • 1. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
    He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A; Sweet K
    J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.
    Tang H; Panse G; Braddock D; Perincheri S; Xu ML; McNiff JM
    J Cutan Pathol; 2023 Jul; 50(7):595-600. PubMed ID: 37082914
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
    Nong L; Wang W; Liang L; Li D; Li X; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
    Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
    Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review.
    Wang Y; Xiao L; Yin L; Zhou L; Deng Y; Deng H
    Medicine (Baltimore); 2023 Feb; 102(7):e32904. PubMed ID: 36800625
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dendritic Cell Leukemia: a Review.
    Tsagarakis NJ; Paterakis G
    Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X; Sun J; Yang M; Wang L; Jin J
    Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.
    Sumarriva Lezama L; Chisholm KM; Carneal E; Nagy A; Cascio MJ; Yan J; Chang CC; Cherry A; George TI; Ohgami RS
    Histopathology; 2018 Nov; 73(5):767-776. PubMed ID: 29884995
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and tcl1a rearrangement.
    Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
    Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
    Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
    Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.
    Julia F; Dalle S; Duru G; Balme B; Vergier B; Ortonne N; Vignon-Pennamen MD; Costes-Martineau V; Lamant L; Dalac S; Delattre C; Déchelotte P; Courville P; Carlotti A; De Muret A; Fraitag S; Levy A; Mitchell A; Petrella T
    Am J Surg Pathol; 2014 May; 38(5):673-80. PubMed ID: 24441662
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
    Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
    Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.
    Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Mahfouz RA; Hamadani M
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1006-12. PubMed ID: 23396213
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm.
    Piccin A; Morello E; Svaldi M; Haferlach T; Facchetti F; Negri G; Vecchiato C; Fisogni S; Pusceddu I; Cortelazzo S
    Hematol Oncol; 2012 Dec; 30(4):210-3. PubMed ID: 22915052
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
    Cota C; Vale E; Viana I; Requena L; Ferrara G; Anemona L; Metze D; Fink-Puches R; Wiesner T; Cerroni L
    Am J Surg Pathol; 2010 Jan; 34(1):75-87. PubMed ID: 19956058
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. T-cell prolymphocytic leukemia involving extramedullary sites.
    Valbuena JR; Herling M; Admirand JH; Padula A; Jones D; Medeiros LJ
    Am J Clin Pathol; 2005 Mar; 123(3):456-64. PubMed ID: 15716243
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. tcl1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories.
    Herling M; Khoury JD; Washington LT; Duvic M; Keating MJ; Jones D
    Blood; 2004 Jul; 104(2):328-35. PubMed ID: 15044256
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.